Skip to content
  • Twitter
  • YouTube
ataxia-global-initiative

ataxia-global-initiative

worldwide platform for clinical research in ataxias

  • Home
  • About
    • SCA
    • ARCA
  • Governance
    • Charter
    • Membership
    • Partnership
    • Steering Committee
    • Ataxia Global Initiative Office
  • Working Groups
    • #1 Clinical outcome assessments & registries
    • #2 Molecular biomarkers & biosampling
    • #3 MRI biomarkers
    • #4 Digital-motor biomarkers
    • #5 Model systems & preclinical trials
    • #6 Next-generation genomics & platforms
    • #7 Policy and patient organization engagement
    • #8 Young investigator initiative
  • Projects
  • Resources
    • SARA Training Tool
    • Massachusetts General Hospital Ataxia Center Noon Conference
    • AGI YII webinar series
    • SCAsource
    • ERN-RND Ataxia Webinars
  • Young Investigator Initiative
    • Young Investigator Initiative (YII)
    • Training Curriculum
      • Ataxia scales training
      • AGI YII webinar series
      • Massachusetts General Hospital Ataxia Center Noon Conference
    • Members of the Young Investigator Initiative
    • Young Investigator Travel Award 2022
    • NAF Travel Award 2020
  • Events
    • Ataxia Global Conference 2022
      • Program
      • Young Investigator travel award
    • AGI’s Tools & Methods studio series
    • AGI symposium 2021
      • Program
    • SCA & ARCA Global Conference 2020
      • Programme & recorded sessions
      • Abstracts
      • Sponsors Online Booth
        • UCB
        • Cadent Therapeutics
        • uniQure
        • Biohaven pharmaceuticals
        • Roche
        • Ionis
        • Vico Therapeutics
        • Triplet Therapeutics
        • IXICO
    • Past events
  • News
    • News
    • Newsletters
  • Contact
  • Twitter
  • YouTube

Category: News

Viewpoint: “Paving the Way Toward Meaningful Trials in Ataxias: An Ataxia Global Initiative Perspective”

Viewpoint: “Paving the Way Toward Meaningful Trials in Ataxias: An Ataxia Global Initiative Perspective”

Continue reading “Viewpoint: “Paving the Way Toward Meaningful Trials in Ataxias: An Ataxia Global Initiative Perspective””

Author Comms ataxia globalPosted on April 29, 2022Categories NewsTags viewpoint

Review article: “The ARCA Registry: A Collaborative Global Platform for Advancing Trial Readiness in Autosomal Recessive Cerebellar Ataxias”

Review article: “The ARCA Registry: A Collaborative Global Platform for Advancing Trial Readiness in Autosomal Recessive Cerebellar Ataxias”

Continue reading “Review article: “The ARCA Registry: A Collaborative Global Platform for Advancing Trial Readiness in Autosomal Recessive Cerebellar Ataxias””

Author Comms ataxia globalPosted on August 23, 2021September 2, 2021Categories News

Launch of Critical Path to Therapeutics for the Ataxias (CPTA) Consortium

Launch of Critical Path to Therapeutics for the Ataxias (CPTA) Consortium

Continue reading “Launch of Critical Path to Therapeutics for the Ataxias (CPTA) Consortium”

Author Comms ataxia globalPosted on March 11, 2021March 11, 2021Categories News

SCA & ARCA Global Conference 2020 – recorded sessions/flash talks & abstracts

SCA & ARCA Global Conference 2020 – recorded sessions/flash talks & abstracts

Continue reading “SCA & ARCA Global Conference 2020 – recorded sessions/flash talks & abstracts”

Author Comms ataxia globalPosted on December 21, 2020December 21, 2020Categories News

SARA training tool by DZNE

SARA training tool by DZNE

Continue reading “SARA training tool by DZNE”

Author Comms ataxia globalPosted on October 29, 2020October 29, 2020Categories News

Research article: “Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3”

Research article: “Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3”

Continue reading “Research article: “Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3””

Author Comms ataxia globalPosted on October 23, 2020October 23, 2020Categories News

European Spinocerebellar Ataxia Type 3/Machado-Joseph Disease Initiative (ESMI) –lay summary of the results of this 4-year Consortium study

European Spinocerebellar Ataxia Type 3/Machado-Joseph Disease Initiative (ESMI) –lay summary of the results of this 4-year Consortium study

Continue reading “European Spinocerebellar Ataxia Type 3/Machado-Joseph Disease Initiative (ESMI) –lay summary of the results of this 4-year Consortium study”

Author Comms ataxia globalPosted on September 10, 2020November 27, 2020Categories News

Research article: “Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study”

Research article: “Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study”

Continue reading “Research article: “Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study””

Author Comms ataxia globalPosted on September 1, 2020September 1, 2020Categories News

SCA & ARCA Global Conference 2020 moves online!

SCA & ARCA Global Conference 2020 moves online!

Continue reading “SCA & ARCA Global Conference 2020 moves online!”

Author Comms ataxia globalPosted on May 29, 2020May 29, 2020Categories News

ARCA Global Conference POSTPONED

ARCA Global Conference POSTPONED

Continue reading “ARCA Global Conference POSTPONED”

Author Comms ataxia globalPosted on March 2, 2020June 11, 2020Categories News

Posts navigation

Page 1 Page 2 Next page

imprint, disclaimer and data-protection

  • Twitter
  • YouTube
We serve cookies on this site to analyse traffic, remember your preferences, and optimise your experience.OKNo 3rd party cookiesData Protection